Published in Vaccine on February 06, 2009
"Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events. J Infect Dis (2009) 1.77
Ontology-based combinatorial comparative analysis of adverse events associated with killed and live influenza vaccines. PLoS One (2012) 1.21
The Saudi Thoracic Society guidelines for influenza vaccinations. Ann Thorac Med (2015) 1.06
From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination. Vaccine (2011) 1.05
Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. Am J Epidemiol (2009) 1.04
The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why? PLoS Curr (2010) 0.95
Introducing seasonal influenza vaccine in low-income countries: an adverse events following immunization survey in the Lao People's Democratic Republic. Influenza Other Respir Viruses (2015) 0.92
Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol (2015) 0.83
Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015). Hum Vaccin Immunother (2015) 0.81
The "urban myth" of the association between neurological disorders and vaccinations. J Prev Med Hyg (2015) 0.81
Safety of pandemic (H1N1) 2009 monovalent vaccines in taiwan: a self-controlled case series study. PLoS One (2013) 0.80
A review of the changes to the licensing of influenza vaccines in Europe. Influenza Other Respir Viruses (2016) 0.80
Mandatory influenza vaccination for health care workers as the new standard of care: a matter of patient safety and nonmaleficent practice. Am J Public Health (2013) 0.79
Self-reported adverse reactions in 4337 healthcare workers immunizations against novel H1N1 influenza. BMC Res Notes (2011) 0.78
Effectiveness of influenza vaccination for preventing influenza-related complications in people with asthma: a systematic review protocol. BMJ Open (2016) 0.77
Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015. Vaccine (2016) 0.76
No evidence of a link between influenza vaccines and Guillain-Barre syndrome-associated antiganglioside antibodies. Influenza Other Respir Viruses (2011) 0.76
Deaths following vaccination: What does the evidence show? Vaccine (2015) 0.76
Influenza vaccination: key facts for general practitioners in Europe-a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands. Drugs Context (2016) 0.75
Clinical Features of Post-Vaccination Guillain-Barré Syndrome (GBS) in Korea. J Korean Med Sci (2017) 0.75
Frequently asked questions on seven rare adverse events following immunization. J Prev Med Hyg (2017) 0.75
A case of myositis of the deltoid muscle of the upper arm developing 1 week after influenza vaccination: case report. Clin Case Rep (2014) 0.75
Analysis of Individual Differences in Vaccine Pharmacovigilance Using VAERS Data and MedDRA System Organ Classes: A Use Case Study With Trivalent Influenza Vaccine. Biomed Inform Insights (2017) 0.75
Viral RNA in the influenza vaccine may have contributed to the development of ANCA-associated vasculitis in a patient following immunisation. Clin Rheumatol (2015) 0.75
Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA (2009) 5.58
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep (2007) 5.32
A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001. Pharmacoepidemiol Drug Saf (2004) 2.37
Perspectives on the use of data mining in pharmaco-vigilance. Drug Saf (2005) 2.00
Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine (2010) 1.99
Adverse events reported following live, cold-adapted, intranasal influenza vaccine. JAMA (2005) 1.84
Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet (2013) 1.82
A novel technique of retrograde nasal intubation for the Pierre Robin Sequence infant with a known difficult airway. Paediatr Anaesth (2009) 1.80
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J (2004) 1.76
The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety. Pharmacoepidemiol Drug Saf (2012) 1.73
Efficacy of radiofrequency ablation for twin-reversed arterial perfusion sequence. Am J Obstet Gynecol (2007) 1.70
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001. MMWR Surveill Summ (2003) 1.70
Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010. Transfusion (2012) 1.66
Blood use by inpatient elderly population in the United States. Transfusion (2007) 1.63
Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics (2008) 1.63
Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol (2012) 1.56
Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007. Vaccine (2008) 1.48
Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010. Am J Epidemiol (2013) 1.46
Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative. Int J Parasitol (2003) 1.46
Anesthesia for in utero repair of myelomeningocele. Anesthesiology (2013) 1.45
Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative. Circ Cardiovasc Qual Outcomes (2014) 1.41
Text mining for the Vaccine Adverse Event Reporting System: medical text classification using informative feature selection. J Am Med Inform Assoc (2011) 1.36
Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010. Am J Epidemiol (2012) 1.28
Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol (2010) 1.25
Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol (2011) 1.25
Cloning, yeast expression, isolation, and vaccine testing of recombinant Ancylostoma-secreted protein (ASP)-1 and ASP-2 from Ancylostoma ceylanicum. J Infect Dis (2004) 1.24
Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine (2010) 1.21
Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J Infect Dis (2008) 1.18
Comparing data mining methods on the VAERS database. Pharmacoepidemiol Drug Saf (2005) 1.10
Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safety. Pediatrics (2011) 1.09
Comparison of Medicare claims versus physician adjudication for identifying stroke outcomes in the Women's Health Initiative. Stroke (2014) 1.05
Vaccine adverse event text mining system for extracting features from vaccine safety reports. J Am Med Inform Assoc (2012) 1.01
Using simulation to assess the sensitivity and specificity of a signal detection tool for multidimensional public health surveillance data. Stat Med (2005) 0.98
Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases. Vaccine (2006) 0.95
Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005. Vaccine (2007) 0.94
Effect of vaccinations with recombinant fusion proteins on Ancylostoma caninum habitat selection in the canine intestine. J Parasitol (2002) 0.93
Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program. Pediatrics (2011) 0.93
Surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2009-2010. Am J Public Health (2012) 0.93
Intussusception and rotavirus vaccination: a review of the available evidence. Expert Rev Vaccines (2009) 0.93
The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise. Pharmacoepidemiol Drug Saf (2012) 0.92
Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine. JAMA (2004) 0.92
Effect of vaccination with a recombinant fusion protein encoding an astacinlike metalloprotease (MTP-1) secreted by host-stimulated Ancylostoma caninum third-stage infective larvae. J Parasitol (2003) 0.91
Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003. Pediatrics (2005) 0.91
Application of information retrieval approaches to case classification in the vaccine adverse event reporting system. Drug Saf (2013) 0.91
Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007. Pediatr Infect Dis J (2009) 0.90
Zidovudine and perinatal human immunodeficiency virus type 1 transmission: a population-based approach. Pediatrics (2002) 0.90
Effects of stratification on data mining in the US Vaccine Adverse Event Reporting System (VAERS). Drug Saf (2008) 0.90
Evaluating adverse events after vaccination in the Medicare population. Pharmacoepidemiol Drug Saf (2007) 0.89
A global regulatory science agenda for vaccines. Vaccine (2013) 0.89
Hyperimmune globulins and same-day thrombotic adverse events as recorded in a large healthcare database during 2008-2011. Am J Hematol (2013) 0.87
Monitoring vaccine safety during an influenza pandemic. Yale J Biol Med (2005) 0.87
Network analysis of possible anaphylaxis cases reported to the US vaccine adverse event reporting system after H1N1 influenza vaccine. Stud Health Technol Inform (2011) 0.87
Adverse event reports following vaccination for Lyme disease: December 1998-July 2000. Vaccine (2002) 0.86
The risk of immune thrombocytopenic purpura after vaccination in children and adolescents. Pediatrics (2012) 0.86
Babesiosis among elderly Medicare beneficiaries, United States, 2006-2008. Emerg Infect Dis (2012) 0.86
Outpatient transfusions and occurrence of serious noninfectious transfusion-related complications among US elderly, 2007-2008: utility of large administrative databases in blood safety research. Transfusion (2012) 0.86
Tuberculin skin testing surveillance of health care personnel. Clin Infect Dis (2002) 0.85
Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002. Clin Infect Dis (2004) 0.85
Evaluation of Guillain-Barré Syndrome among recipients of influenza vaccine in 2000 and 2001. Am J Prev Med (2010) 0.83
Outpatient urticaria diagnosis codes have limited predictive value for same-day influenza vaccine adverse event detection. J Clin Epidemiol (2009) 0.83
Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System. Clin Infect Dis (2003) 0.83
Vaccine risk perception among reporters of autism after vaccination: vaccine adverse event reporting system 1990-2001. Am J Public Health (2004) 0.81
Assessing influenza vaccine utilization in physician offices serving adult patients: experience during a season of vaccine delays and shortages. J Public Health Manag Pract (2007) 0.81
Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance. Health Aff (Millwood) (2012) 0.81
Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization. Vaccine (2008) 0.81
Intussusception following rotavirus vaccination: an updated review of the available evidence. Expert Rev Vaccines (2014) 0.81
Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010. Clin Infect Dis (2012) 0.81
Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): implications for assessment of suspected vaccine-provoked vasculitis. J Rheumatol (2004) 0.80
Congenital diaphragmatic hernia associated with spinal anomalies. Obstet Gynecol (2007) 0.80
Fetoscopic transuterine release of posterior urethral valves: a new technique. Fetal Diagn Ther (2007) 0.80
Identifying Similar Cases in Document Networks Using Cross-Reference Structures. IEEE J Biomed Health Inform (2014) 0.79
Letter to the Editor. Guillain-Barré Syndrome(GBS) after vaccination reported to the United States Vaccine Adverse Event Reporting System(VAERS) in 2004. Vaccine (2007) 0.77
Death and serious illness following influenza vaccination: a multidisciplinary investigation. Pharmacoepidemiol Drug Saf (2009) 0.77
Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007 [Vaccine 2009;27:290-297]. Vaccine (2009) 0.77
Fatal syncope-related fall after immunization. Arch Pediatr Adolesc Med (2005) 0.77
Pre-emptive placement of a presealant for amniotic access. Am J Obstet Gynecol (2005) 0.77
Developmental regression and autism reported to the Vaccine Adverse Event Reporting System. Autism (2007) 0.77
Thrombocytopenia after vaccination: case reports to the US Vaccine Adverse Event Reporting System, 1990-2008. Vaccine (2010) 0.77
Adverse events after hepatitis A B combination vaccine. Vaccine (2005) 0.76
Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006. Vaccine (2008) 0.76